New Key Statistics Module, Z-Score and F-Score
NAS:SPRO Key Ratios
Market Cap $ M | 81.52 |
Enterprise Value $ M | 7.19 |
P/E(ttm) | 3.55 |
PE Ratio without NRI | 3.00 |
Forward PE Ratio | -- |
Price/Book | 0.87 |
Price/Sales | 0.84 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 100.00 |
EPS (TTM) $ | 0.44 |
Beneish M-Score | 12.74 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.29 |
EV-to-EBITDA | 0.29 |
PEG | -- |
Shares Outstanding M | 53.99 |
Net Margin (%) | 23.36 |
Operating Margin % | 26.98 |
Pre-tax Margin (%) | 25.95 |
Quick Ratio | 3.35 |
Current Ratio | 3.35 |
ROA % (ttm) | 17.50 |
ROE % (ttm) | 31.08 |
ROIC % (ttm) | 50.65 |
Dividend Yield % | -- |
Altman Z-Score | -0.85 |
SPRO Number of Guru Trades
SPRO Volume of Guru Trades
Gurus Latest Trades with NAS:SPRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SPRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spero Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SPRO
Total 0- 1